Literature DB >> 12089390

Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study.

William M McClellan1, W Dana Flanders, Robert D Langston, Claudine Jurkovitz, Rodney Presley.   

Abstract

The purpose of this retrospective cohort study was to examine the associations among chronic kidney disease, anemia, and risk of death among patients with heart failure. Retrospective cohort study. Patients with a principal diagnosis of heart failure (ICD9 codes 402.01, 402.11, 402.91, 404.01, 404.11, 404.91, and 428.xx) were included. Chronic kidney disease (CKD) was defined as a serum creatinine >1.4 mg/dl for women and >1.5 mg/dl for men. There were 665 eligible patients in the sample with a mean (SD) age of 75.7 (10.9) yr; 60% were women, 71% were white, and 38% had CKD. On admission, a hematocrit > or =40% was found for 30.3% of the patients; 22.9% had a hematocrit between 36% and 40%, 33.2% between 30% and 35%, and 13.6% had a hematocrit of <30%. The 1-yr death rates among individuals with and without CKD were 44.9% and 31.4%, respectively (relative risk [RR], 1.43; 95% confidence interval [CI], 1.17 to 1.75). The mortality at 1 yr was 31.2% for individuals with a hematocrit > or =40%; 33.8% (RR, 1.08; 95% CI. 0.79 to 1.47) for hematocrit 36 to 39%; 36.7% (RR, 1.17; 95% CI, 0.89 to 1.54) for hematocrit between 30 and 35%; and 50.0% (RR, 1.60; 95% CI, 1.19 to 2.16) for those with a hematocrit <30% (chi(2) for trend was 7.37; P = 0.007). Both hematocrit and serum creatinine were independently associated with increased risk of death during follow-up after controlling for other patient risk factors. In conclusion, CKD and anemia are frequent among older patients with heart failure and are independent predictors of subsequent risk of death.

Entities:  

Mesh:

Year:  2002        PMID: 12089390     DOI: 10.1097/01.asn.0000018409.45834.fa

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  84 in total

1.  Anaemia and heart failure.

Authors:  A J S Coats
Journal:  Heart       Date:  2004-09       Impact factor: 5.994

Review 2.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

Review 3.  Systolic heart failure in the elderly: optimizing medical management.

Authors:  Jonathan P Man; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

4.  Beta blocker treatment is associated with improvement in renal function and anaemia in patients with heart failure.

Authors:  W Khan; S M Deepak; T Coppinger; C Waywell; A Borg; L Harper; S G Williams; N H Brooks
Journal:  Heart       Date:  2006-12       Impact factor: 5.994

5.  Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD.

Authors:  Simon de Denus; Jean-Claude Tardif; Michel White; Martial G Bourassa; Normand Racine; Sylvie Levesque; Anique Ducharme
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

6.  Erythropoietin in cardiorenal anemia syndrome.

Authors:  Emir Fazlibegović; Mustafa Hadziomerović; Slavica Corić; Emil Babić; Fadila Fazlibegović
Journal:  Bosn J Basic Med Sci       Date:  2006-11       Impact factor: 3.363

Review 7.  A perspective on diuretic resistance in chronic congestive heart failure.

Authors:  Niel Shah; Raef Madanieh; Mehmet Alkan; Muhammad U Dogar; Constantine E Kosmas; Timothy J Vittorio
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-07-20

8.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

Review 9.  Effect of daprodustat on anemia in patients with chronic kidney disease: a meta-analysis.

Authors:  Dengpiao Xie; Jianting Wang; Xinping Wu; Mingquan Li
Journal:  Int Urol Nephrol       Date:  2018-08-02       Impact factor: 2.370

10.  Continuous renal replacement therapy versus furosemide for management of kidney impairment in heart transplant recipients with volume overload.

Authors:  Seyed Mohsen Mirhosseini; Mohammad Fakhri; Shadi Asadollahi; Zargham Hossein Ahmadi; Farin Rashid Farokhi; Mohammad Reza Boloursaz; Mohammad Reza Masjedi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.